These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 18193637)

  • 1. The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics.
    Brown EM
    Subcell Biochem; 2007; 45():139-67. PubMed ID: 18193637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations.
    Egbuna OI; Brown EM
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):129-48. PubMed ID: 18328986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathophysiology of primary hyperparathyroidism.
    Brown EM
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N24-9. PubMed ID: 12412774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The calcium-sensing receptor (CaR) permits Ca2+ to function as a versatile extracellular first messenger.
    Brown EM; Chattopadhyay N; Vassilev PM; Hebert SC
    Recent Prog Horm Res; 1998; 53():257-80; discussion 280-1. PubMed ID: 9769711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular calcium-sensing receptor: structural and functional features and association with diseases.
    Hauache OM
    Braz J Med Biol Res; 2001 May; 34(5):577-84. PubMed ID: 11323743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial hypocalciuric hypercalcemia and other disorders with resistance to extracellular calcium.
    Brown EM
    Endocrinol Metab Clin North Am; 2000 Sep; 29(3):503-22. PubMed ID: 11033758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
    Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
    Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor.
    Kifor O; Moore FD; Delaney M; Garber J; Hendy GN; Butters R; Gao P; Cantor TL; Kifor I; Brown EM; Wysolmerski J
    J Clin Endocrinol Metab; 2003 Jan; 88(1):60-72. PubMed ID: 12519831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-sensing receptor and associated diseases.
    Hendy GN; Guarnieri V; Canaff L
    Prog Mol Biol Transl Sci; 2009; 89():31-95. PubMed ID: 20374733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcimimetic and Calcilytic Drugs: Feats, Flops, and Futures.
    Nemeth EF; Goodman WG
    Calcif Tissue Int; 2016 Apr; 98(4):341-58. PubMed ID: 26319799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptors.
    Rus R; Haag C; Bumke-Vogt C; Bähr V; Mayr B; Möhlig M; Schulze E; Frank-Raue K; Raue F; Schöfl C
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4797-803. PubMed ID: 18796518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The First Annual Bayard D. Catherwood Memorial Lecture. Ca2+-receptor-mediated regulation of parathyroid and renal function.
    Brown EM; Hebert SC
    Am J Med Sci; 1996 Sep; 312(3):99-109. PubMed ID: 8783675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diseases associated with the extracellular calcium-sensing receptor.
    Thakker RV
    Cell Calcium; 2004 Mar; 35(3):275-82. PubMed ID: 15200151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating mutations of the Ca2+-sensing receptor.
    Mancilla EE; De Luca F; Baron J
    Mol Genet Metab; 1998 Jul; 64(3):198-204. PubMed ID: 9719629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.
    Bai M; Pearce SH; Kifor O; Trivedi S; Stauffer UG; Thakker RV; Brown EM; Steinmann B
    J Clin Invest; 1997 Jan; 99(1):88-96. PubMed ID: 9011580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology and clinical importance of the Ca(2+)-sensing receptor.
    De Luca F; Baron J
    Curr Opin Pediatr; 1998 Aug; 10(4):435-40. PubMed ID: 9757371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium-sensing receptor and calcimimetic agents.
    Coburn JW; Elangovan L; Goodman WG; Frazaõ JM
    Kidney Int Suppl; 1999 Dec; 73():S52-8. PubMed ID: 10633465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and functional characterization of extracellular Ca(2+)-sensing receptors from parathyroid and kidney.
    Brown EM; Pollak M; Chou YH; Seidman CE; Seidman JG; Hebert SC
    Bone; 1995 Aug; 17(2 Suppl):7S-11S. PubMed ID: 8579901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the calcium-sensing receptor and their clinical implications.
    Brown EM
    Horm Res; 1997; 48(5):199-208. PubMed ID: 9362389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the extracellular calcium-sensing receptor in health and disease.
    Raue F; Haag C; Schulze E; Frank-Raue K
    Exp Clin Endocrinol Diabetes; 2006 Sep; 114(8):397-405. PubMed ID: 17039419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.